National Comprehensive Cancer Network

Interactive CME


Educational Events & Programs

NCCN POLICY SUMMIT DATE  >  Monday, June 25, 2018 > Register!

NCCN POLICY SUMMIT LOCATION  > The National Press Club • Washington, DC

 

 

Keynote Speaker:
Scott Gottlieb, MD (view bio)
23rd Commissioner of the Food and Drug Administration (FDA)

 

 

 

 

 

OVERVIEW

The summit will explore the impact of new innovations and the rapidly shifting health policy landscape on access to high-quality cancer care in the United States. Experts in the field will identify strategies to ensure access to and affordability of innovation and novel therapies, review current FDA policies intended to make oversight more effective and efficient, and discuss recent healthcare regulations and legislation and their real world implications for oncology stakeholders.

Please check back often for additional updates regarding the summit. If you have any meeting content or agenda questions, please contact Alyssa Schatz, Director, Policy and Advocacy, U.S. and Global Development. For any media questions, please contact Rachel Darwin, Public Relations Manager.


AGENDA TOPICS*

8:30 – 9:30 AM

Breakfast and Registration

9:30 – 9:40 AM

Welcome and Introductions

Robert W. Carlson, MD
National Comprehensive Cancer Network

9:40 – 10:30 AM

Accelerating Access to Innovation

Keynote Speaker:
Scott Gottlieb, MD
Food and Drug Administration (FDA)

10:30 – 10:40 AM

Break

10:40 AM – 12:00 PM

Panel Discussion – Paying for Innovation

Moderator:
Clifford Goodman, PhD
Senior Vice President
The Lewin Group

Panelists:
Stephanie Farnia, MPH
The American Society for Blood and Marrow Transplantation (ASBMT)

Meghan Gutierrez
Lymphoma Research Foundation

Caron A. Jacobson, MD
Dana-Farber/Brigham and Women’s Cancer Center 
Massachusetts General Hospital Cancer Center

Stefanie Joho

Ellen Lukens
Center for Medicare and Medicaid Innovation (CMMI)

Pavan Reddy, MD
Kansas Society of Clinical Oncology
Cancer Center of Kansas

Michael Ybarra, MD
PhRMA

12:00 –12:50 PM

Lunch

12:50 – 1:10 PM

Network Adequacy in the ACA Exchange: Narrow Network Implications for Access to High Quality Academic Cancer Centers

Alyssa Schatz, MSW
National Comprehensive Cancer Network

1:10 – 2:30 PM

Panel Discussion –The Evolving Healthcare Landscape: Implications for Access to Quality Cancer Care

Moderator:
Clifford Goodman, PhD
The Lewin Group

Panelists:

Joseph Alvarnas, MD, MS
City of Hope Comprehensive Cancer Center

Joseph R. Antos, PhD
American Enterprise Institute

Jennifer Carlson
Ohio State University, Wexler Medical Center

John Cox, MD
UT Southwestern, Parkland Health and Hospital System

Elizabeth Franklin, LGSW, ACSW
Cancer Support Community

Anna Griffin
Kite, A Gilead Company

Kavita Patel, MD
Brookings Institution

Alyssa Schatz, MSW
National Comprehensive Cancer Network

2:30 – 3:15 PM

Cancer Policy in 2018

3:15 PM 

Wrap-up and Conclusions

Robert W. Carlson, MD
National Comprehensive Cancer Network


*Subject to change.


SUPPORTERS

Supported by Adaptive Biotechnologies. Supported by AmerisourceBergen. Supported by an educational donation provided by Amgen. Supported by Astellas. Supported by AstraZeneca through its NCCN Corporate Council Membership. Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. Supported by Celgene Corporation. Sponsored by Clovis Oncology, Inc. Sponsored by Dendreon. Supported by Eisai, Inc. Supported by EMD Serono. Supported by a non-restricted medical education grant from Gilead Sciences, Inc. Supported by HELSINN. Supported by Heron. Supported by Incyte Corporation. Supported by Janssen Pharmaceutical Companies of Johnson & Johnson. Supported by Juno Therapeutics. This activity is supported by a contribution from Lilly. Supported by an independent educational grant from Merck & Co., Inc. Sponsored by Novartis Pharmaceuticals Corporation. This activity was made possible by Pharmacyclics, an AbbVie Company and Janssen Biotech, Inc. Supported by Regeneron. Sponsored by Sandoz, A Novartis Division. Supported by an unrestricted sponsorship from TESARO. Supported by Verastem.

As of April 26, 2018


Access the Library of White Papers!

NCCN offers a broad library of white papers from previous summits that may be pertinent to your organization.

View Supporter Opportunities.

NCCN offers organizations various supporter opportunities.